Martin Steven Robert 4
4 · APRICUS BIOSCIENCES, INC. · Filed Feb 1, 2013
Insider Transaction Report
Form 4
Martin Steven Robert
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2013-01-31+2,500→ 2,500 totalExercise: $2.64Exp: 2023-01-31→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The option is fully vested as of the date of grant.